+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead

Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead

Plos One 6(7): E20432

Epidemiologic studies are reporting associations between lead exposure and human cancers. A polymorphism in the 5-aminolevulinic acid dehydratase (ALAD) gene affects lead toxicokinetics and may modify the adverse effects of lead. The objective of this study was to evaluate single-nucleotide polymorphisms (SNPs) tagging the ALAD region among renal cancer cases and controls to determine whether genetic variation alters the relationship between lead and renal cancer. Occupational exposure to lead and risk of cancer was examined in a case-control study of renal cell carcinoma (RCC). Comprehensive analysis of variation across the ALAD gene was assessed using a tagging SNP approach among 987 cases and 1298 controls. Occupational lead exposure was estimated using questionnaire-based exposure assessment and expert review. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using logistic regression. The adjusted risk associated with the ALAD variant rs8177796(CT/TT) was increased (OR = 1.35, 95%CI = 1.05-1.73, p-value = 0.02) when compared to the major allele, regardless of lead exposure. Joint effects of lead and ALAD rs2761016 suggest an increased RCC risk for the homozygous wild-type and heterozygous alleles ((GG)OR = 2.68, 95%CI = 1.17-6.12, p = 0.01; (GA)OR = 1.79, 95%CI = 1.06-3.04 with an interaction approaching significance (p(int) = 0.06). No significant modification in RCC risk was observed for the functional variant rs1800435(K68N). Haplotype analysis identified a region associated with risk supporting tagging SNP results. A common genetic variation in ALAD may alter the risk of RCC overall, and among individuals occupationally exposed to lead. Further work in larger exposed populations is warranted to determine if ALAD modifies RCC risk associated with lead exposure.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 052269671

Download citation: RISBibTeXText

PMID: 21799727

Related references

Delta-aminolevulinic acid dehydratase (ALAD) polymorphism in lead exposed Bangladeshi children and its effect on urinary aminolevulinic acid (ALA). Environmental Research 136: 318-323, 2015

Delta-aminolevulinic acid dehydratase (ALAD) polymorphism and susceptibility of workers exposed to inorganic lead and its effects on neurobehavioral functions. Neurotoxicology 25(6): 1041-1047, 2004

The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Environmental Health Perspectives 109(8): 827-832, 2001

Lead concentration in the blood and aminolevulinic acid dehydratase (ALAD) activity in the erythrocytes depending on sex, age, tobacco smoking and alcohol drinking in the group of persons exposed to industrial dust. Medycyna Pracy 32(2): 99-107, 1981

Association between delta-aminolevulinic acid dehydratase (ALAD) polymorphism and blood lead levels: a meta-regression analysis. Journal of Toxicology and Environmental Health. Part a 70(23): 1986-1994, 2007

A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study. Environmental Health Perspectives 111(3): 335-341, 2003

Influence of delta-aminolevulinic acid dehydratase (ALAD) polymorphism on the frequency of sister chromatid exchange (SCE) and the number of high-frequency cells (HFCs) in lymphocytes from lead-exposed workers. Mutation Research 540(1): 79-88, 2003

Ethnicity affects the distribution of delta-aminolevulinic acid dehydratase (ALAD) genetic variants. Clinica Chimica Acta; International Journal of Clinical Chemistry 367(1-2): 192-195, 2006

Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacology & Toxicology 81(4): 153-158, 1997

Increase of delta-aminolevulinic acid dehydratase (ALAD) in rat erythrocytes in lead poisoning. Archives of Toxicology 52(1): 1-11, 1983

Erythrocytic aminolevulinic acid dehydratase (ALAD) activity as a biologic parameter for determining exposures to lead. Journal of Occupational Medicine. 17(3): 157-162, 1975

Renal delta-aminolevulinic acid excretion in persons not exposed to lead. Zentralblatt für Arbeitsmedizin, Arbeitsschutz, Prophylaxe und Ergonomie 32(6): 210-212, 1982

Lead accumulation and depression of delta-aminolevulinic acid dehydratase (ALAD) in young birds fed automotive waste oil. Archives of Environmental Contamination and Toxicology 12(1): 31-35, 1983

Determination of delta-aminolevulinic acid dehydratase (ALAD) by enzyme immunoassay and its application to evaluation of lead exposure. Sangyo Igaku. Japanese Journal of Industrial Health 30(4): 248-255, 1988